your badges 52W Range $3–$8 9% of range Analyst Rating STRONG BUY 17 analysts Price Target $16 +337% upside P/E -2.4 ROE 524.0% Net Profit Margin -7899.6%

IVA Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

03
Price $3.56
P/E -2.4
EPS $-1.90
Revenue $4M
ROE 524.0%
52W Range $3–$8

IVA Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

04
range
bars

Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.

10-Year Performance Revenue, net income, margins and EPS trends

06
Revenue$4M
2018-12-31 → 2025-12-31
EPS$-1.90
2019-12-31 → 2025-12-31
Net margin-7899.6%
2020-12-31 → 2025-12-31
Valuation & Ratios 07–12

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric 5Y trend IVA 5Y avg Peer Median Verdict
P/E -2.45Y avg ≈-3.8 ≈-3.8 · ·

Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.

value · ≈ 5Y avg · industry median · verdict relative to median

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

14
Avg Surprise 33.5%
PeriodReportEPS ActualEPS EstSurprise
June 30, 2026 $-0.25 $-0.38 33.5%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

15
Income Statement 13
Metric Trend 20252024202320222021202020192018
Revenue $4M$9M$17M$12M$4M$372.0K$7M$3M
R&D Expense $87M$91M$110M$60M$48M$24M$34M$32M
SG&A Expense $48M$16M$14M$13M$11M$8M$6M$6M
Operating Income $-141M$-98M$-103M$-57M$-52M$-30M$-30M$-33M
Interest Expense $34M$12M$5M$584.0K$138.0K$66.0K$3.0K$4.0K
Interest Income $4M$3M$2M$5M$5M$2M$175.0K$142.0K
Income Tax $22.0K$313.0K$607.0K$-20.0K$364.0K$0$0·
Net Income $-354M$-184M$-110M$-54M$-50M$-34M$-30M$-33M
EPS (Basic) $-1.90$-3.08$-2.43$-1.31$-1.27$-0.99$-1.28·
EPS (Diluted) $-1.90$-3.08$-2.43$-1.31$-1.27$-0.99$-1.28·
Shares (Basic) 186,801,79259,778,70145,351,79941,449,73239,168,15233,874,75123,519,897·
Shares (Diluted) 186,801,79259,778,70145,351,79941,449,73239,168,15233,874,75123,519,89720,540,979
EBITDA $-141M$-98M$-103M$-57M$-52M$-30M··
Balance Sheet 12
Metric Trend 20252024202320222021202020192018
Cash & Equivalents $17M$26M$9M$70M$44M$94M$22M$15M
Receivables $2M$531.0K$4M$0$4M···
Inventory ·$0$417.0K$373.0K$392.0K$320.0K$387.0K$410.0K
Current Assets $244M$112M$48M$106M$116M$133M$49M$72M
PP&E (Net) ·$5M$9M$7M$3M$3M$4M$5M
Intangibles $182.0K$48.0K$541.0K$568.0K$770.0K$935.0K$1M$2M
Total Assets $250M$119M$70M$116M$122M$139M$57M$80M
Accounts Payable ·$33M$38M$19M$15M$7M$7M·
Current Liabilities $77M$121M$50M$31M$23M$14M$14M$15M
Total Liabilities $278M$226M$102M$71M$33M···
Retained Earnings ·····$-34M$-30M$-33M
Stockholders' Equity $-29M$-107M$-32M$45M$89M$111M$41M$62M
Cash Flow 3
Metric Trend 20252024202320222021202020192018
Operating Cash Flow $-105M$-86M$-82M$-45M$-48M$-31M$-28M$-34M
Investing Cash Flow $-133M$9M$-8M$9M$-2M$-9M$-826.0K$-420.0K
Financing Cash Flow $241M$146M$29M$37M$25M$112M$8M$32M
Profitability 5
Metric Trend 20252024202320222021202020192018
Operating Margin -3145.5%-1060.6%-587.7%-468.9%-1242.6%-7988.7%··
Net Margin -7899.6%-2002.7%-631.8%-445.6%-1183.5%-9037.4%··
EBITDA Margin -3145.5%-1060.6%-587.7%-468.9%-1242.6%-7988.7%··
ROA -192.2%-195.4%-119.0%-45.6%-38.0%-34.3%··
ROE 524.0%265.7%-1642.8%-80.8%-49.6%-44.1%··
Liquidity & Solvency 3
Metric Trend 20252024202320222021202020192018
Current Ratio 3.20.91.03.55.19.6··
Quick Ratio 0.20.20.32.31.96.7··
Interest Coverage -4.2-8.0-19.8-97.8-377.6-450.3··
Efficiency 2
Metric Trend 20252024202320222021202020192018
Asset Turnover 0.00.10.20.10.00.0··
Receivables Turnover 3.54.29.2·····
Per Share 3
Metric Trend 20252024202320222021202020192018
Revenue / Share $0.02$0.15$0.39$0.29$0.11$0.01··
Cash Flow / Share $-0.56$-1.44$-1.80$-1.08$-1.22$-0.90··
EPS (TTM) $-1.90$-3.08$-2.43$-1.31$-1.27$-0.99··
Valuation (TTM) 4
Metric Trend 20252024202320222021202020192018
Revenue TTM $4M$9M$17M$12M$4M$372.0K··
Net Income TTM $-354M$-184M$-110M$-54M$-50M$-34M··
P/E -2.4-0.7-1.9-3.4-10.8-14.6··
Earnings Yield -40.9%-143.9%-53.8%-29.4%-9.3%-6.8%··

Most recent period on the left · null values shown as ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

16
Metric 2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue $4M $9M $17M $12M $4M
Operating Margin % -3145.5% -1060.6% -587.7% -468.9% -1242.6%
Net Income $-354M $-184M $-110M $-54M $-50M
Diluted EPS $-1.90 $-3.08 $-2.43 $-1.31 $-1.27

Institutional owners (13F) 89 filers · $328.6M total · As of June 30, 2026

17

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Holders 89
Value held $328.6M
New positions 32
Exited positions 7
Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
32 (+9 vs prior Q) 7 (-4 vs prior Q) 35 (+16 vs prior Q) 7 (-3 vs prior Q) +33.1M

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
Caligan Partners LP $30,856,862 8,163,191 9.39% Shares
SAMSARA BIOCAPITAL, LLC $23,869,963 6,314,805 7.26% Shares
Paradigm Biocapital Advisors LP $15,120,000 4,000,000 4.60% Shares
ANDERA PARTNERS $13,733,424 3,633,181 4.18% Shares
ADAR1 Capital Management, LLC $13,633,160 3,606,656 4.15% Shares
MILLENNIUM MANAGEMENT LLC $13,276,018 3,512,174 4.04% Shares
SymBiosis Capital Partners, LLC $13,064,700 2,354,000 3.98% Shares
Nantahala Capital Management, LLC $10,154,566 2,686,393 3.09% Shares
Trails Edge Capital Partners, LP $10,047,228 2,657,997 3.06% Shares
FRANKLIN RESOURCES INC $9,989,070 2,642,611 3.04% Shares
Squadron Capital Management LLC $9,204,300 2,435,000 2.80% Shares
Woodline Partners LP $8,781,503 2,323,149 2.67% Shares
Aberdeen Group plc $8,723,382 2,307,773 2.65% Shares
UBS Group AG $8,713,626 2,305,192 2.65% Shares
BOOTHBAY FUND MANAGEMENT, LLC $7,574,296 2,003,782 2.30% Shares
Patient Square Capital LP $7,435,906 1,967,171 2.26% Shares
NEXTBio Capital Management LP $6,758,580 1,787,984 2.06% Shares
CITADEL ADVISORS LLC $6,745,659 1,784,566 2.05% Shares
AMERIPRISE FINANCIAL INC $6,415,219 1,697,148 1.95% Shares
Point72 Asset Management, L.P. $6,361,785 1,683,012 1.94% Shares
Integral Health Asset Management, LLC $5,745,600 1,520,000 1.75% Shares
Yu Fan $5,670,000 1,500,000 1.73% Shares
NEA Management Company, LLC $5,528,575 1,462,586 1.68% Shares
STEMPOINT CAPITAL LP $5,391,490 1,426,320 1.64% Shares
Propel Bio Management, LLC $4,842,981 1,281,212 1.47% Shares
KINGDON CAPITAL MANAGEMENT, L.L.C. $4,800,600 1,270,000 1.46% Shares
JPMORGAN CHASE & CO $4,647,305 1,309,100 1.41% Shares
ADAGE CAPITAL PARTNERS GP, L.L.C. $4,233,600 1,120,000 1.29% Shares
Ikarian Capital, LLC $4,152,521 1,129,101 1.26% Shares
Polar Capital Holdings Plc $4,060,529 1,074,214 1.24% Shares
MARSHALL WACE, LLP $3,651,131 965,907 1.11% Shares
Alyeska Investment Group, L.P. $3,436,020 909,000 1.05% Shares
MORGAN STANLEY $3,408,199 901,640 1.04% Shares
JANE STREET GROUP, LLC $3,407,175 901,369 1.04% Shares
HighVista Strategies LLC $3,142,851 831,442 0.96% Shares
Deep Track Capital, LP $3,024,000 800,000 0.92% Shares
TWO SIGMA INVESTMENTS, LP $2,752,260 728,111 0.84% Shares
DIADEMA PARTNERS LP $2,725,718 740,786 0.83% Shares
BVF INC/IL $2,593,231 686,040 0.79% Shares
FMR LLC $2,590,812 685,400 0.79% Shares
Ally Bridge Group (NY) LLC $2,399,544 634,800 0.73% Shares
Qube Research & Technologies Ltd $1,502,769 397,558 0.46% Shares
J. Goldman & Co LP $1,275,750 337,500 0.39% Shares
Simplify Asset Management Inc. $1,184,966 313,483 0.36% Shares
Artisan Partners Limited Partnership $996,174 263,538 0.30% Shares
Ghisallo Capital Management LLC $945,000 250,000 0.29% Shares
Burkehill Global Management, LP $850,500 225,000 0.26% Shares
SEVEN GRAND MANAGERS, LLC $850,500 225,000 0.26% Shares
GOLDMAN SACHS GROUP INC $848,606 224,499 0.26% Shares
XTX Topco Ltd $809,986 214,282 0.25% Shares

Show all 89 institutional owners →

Activists & 5%+ owners 4 positions

18

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
New Enterprise Associates 17, L.P., NEA Partners 17, L.P., NEA 17 GP, LLC, Growth Equity Opportunities 18 VGE, LLC, NEA 18 Venture Growth Equity, L.P., NEA Partners 18 VGE, L.P., NEA 18 VGE GP, LLC, Forest Baskett, Ali Behbahani, Carmen Chang, Anthony A. Florence, Jr., Mohamad H. Makhzoumi, Edward T. Mathers, Scott D. Sandell, Paul Walker, Rick Yang ×5 filings April 1, 2026 4.90% Amendment Passive investment SEC
BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, BVF PARTNERS L P/IL, BVF INC/IL, LAMPERT MARK N ×3 filings Nov. 19, 2025 4.99% Amendment · SEC
Samsara BioCapital, L.P., Samsara BioCapital GP, LLC, Samsara Opportunity Fund, L.P., Samsara Opportunity Fund GP, LLC, Srinivas Akkaraju ×2 filings Nov. 19, 2025 7.40% Amendment · SEC
BIOTECHNOLOGY VALUE FUND, L.P., BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II, L.P., BVF II GP LLC, BIOTECHNOLOGY VALUE TRADING FUND OS, L.P., BVF PARTNERS OS LTD., BVF GP HOLDINGS LLC, BVF PARTNERS L.P., BVF INC., MARK N. LAMPERT ×4 filings Oct. 21, 2024 · Initial filing · SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

ETF ownership Held by 6 ETFs

20

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
MEDI · Harbor ETF Trust 0.37% 33,996 NS July 31, 2026 N-PORT
IEUS · iShares Trust 0.03% 10,684 SH Sept. 11, 2026 Daily
ISCF · iShares Trust 0.01% 17,398 SH Sept. 11, 2026 Daily
SCZ · iShares Trust 0.01% 320,867 SH Sept. 11, 2026 Daily
WSML · iShares Trust 0.00% 7,665 SH Sept. 11, 2026 Daily
IEFA · iShares Trust 0.00% 713,349 SH Sept. 11, 2026 Daily

IVA Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

21
rating · 17 analysts BUY
Median target $14.00 +293.3%
8 47.1% Strong Buy
8 47.1% Buy
1 5.9% Hold
0 0.0% Sell
0 0.0% Strong Sell

12-Month Price Target

11 analysts · 2026-09-29

Mean target $15.55 +336.7%

← Below all targets Current price $3.56
Low$10.00 Mean$15.55 High$26.00

My Metrics Your personal watchlist — selected rows from Full Fundamentals

26

Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Source: SEC 20-F filed Apr 8, 2026